Senior insider sale
LIGAND PHARMACEUTICALS INC — senior position signals high conviction
$253.9K
1.87K shares
What this filing means
KOZARICH JOHN W plans to sell 1.87K shares of LIGAND PHARMACEUTICALS INC valued at approximately $253.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/2/2025ACC: 0001969223-25-000704
1.87K
Shares to sell
$253.9K
Approx. market value
467.00
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Various
NA
6/9/2023
467.00Total acquired467.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/9/2023 | Various NA | 467.00 | — |
| Total | 467.00 | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
467.00
Market value
$61.6K
8/1/2025
—Completed
Units to sell
934.00
Market value
$116.8K
7/10/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
467.00
Market value
$75.5K
9/2/2025
Total
Units
1.87K
Value
$253.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/1/2025 | 467.00 | $61.6K | — | Completed |
7/10/2025 | 934.00 | $116.8K | — | Completed |
| Planned — Approximate Date | ||||
9/2/2025 | 467.00 | $75.5K | Nasdaq | Planned |
| Total | 1.87K | $253.9K | ||